anonymous
Guest
anonymous
Guest
Enough with the games you would think since March 2020 . The stock would’ve been at an all time high and not at $3.44 per share.Sorry to inform you all but the end is near.Hope this helps!!!!!
Enough with the games you would think since March 2020 . The stock would’ve been at an all time high and not at $3.44 per share.Sorry to inform you all but the end is near.Hope this helps!!!!!
Sounds great, time to short some more!$$$ Keep up the good work.
One thing I do know. How to short a bloated pig. Slopko
This is exactly correct. For 6 months BioReference will run “independently” as a division of Quest Diagnostics. All the while, Quest will gradually increase their profile and shift the business. The “Questies” that receive so much undue criticism on these boards are contracted in with enormous sign on bonuses. Dean is also in. Fein will get a check and will never work in the industry again.
Nothing is done until it’s done. But 90/10 or better and BioReference, a division of Quest Diagnostics will be the new name. For a short while. Congratulations CJ. You are unstoppable
That is why AnthonyHu is back. free egg rolls.Stock at all time low since BRL acquisition, company morale not much better. Silence from the top is deafening. Tick tock tick tock
Stock at all time low since BRL acquisition, company morale not much better. Silence from the top is deafening. Tick tock tick tock
And Cindy will save the day
Is it safe to enter?
No. Your m0ther has numerous STDs. If you actually worked in the clinical laboratory industry you would understand this. M0mmy has blisters, no more gummers for you
Asked and answered. The clowns are still around.